It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...

Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...

HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the past few years. For those who are ...

Ahead of the much-anticipated launch of Novo Nordisk’s blockbuster weight-loss drug Ozempic Wegovy in India, Dr. Reddy’s has ...

A mother has revealed how she lost nine stone in just 12 months without resorting to weight loss jabs or surgery—instead ...

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as ...

In a breakthrough study from Voy, in collaboration with Imperial College London, researchers have confirmed that combining ...

Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...

Misleading ads on social media are promoting products that doctors say are not effective but mimic the names of more ...